CSS
BOLD

Cubist Systematic Strategies’s Boundless Bio BOLD Stock Holding History

Cubist Systematic Strategies’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-520
Closed -$2.01K – 3587
2024
Q2 		$2.01K Buy
+520
New +$4.97K ﹤0.01% 2844

Other funds holding BOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Cubist Systematic Strategies's BOLD Position: Q3 2024 in Review

Cubist Systematic Strategies sold out of Boundless Bio (BOLD) in Q3 2024, closing a stake of 520 shares — an estimated $2.01K sold.

Cubist Systematic Strategies first reported a position in BOLD in Q2 2024 and held it in 1 quarter. The position peaked at $2.01K in Q2 2024. 55 funds tracked by Wall St. Rank hold BOLD as of Q3 2024.

  • Cubist Systematic Strategies reported no remaining Boundless Bio position as of Q3 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 520 Boundless Bio shares in Q3 2024, an estimated $2.01K.
  • Cubist Systematic Strategies first reported a position in Boundless Bio in Q2 2024 and held it in 1 quarter.
  • Cubist Systematic Strategies's Boundless Bio position peaked at $2.01K in Q2 2024.
  • 55 funds tracked by Wall St. Rank held Boundless Bio as of Q3 2024.

Based on Cubist Systematic Strategies's 13F filing for Q3 2024, filed 14 Nov 2024.